RIFAXIGRSS 400

About

RIFAXIGRSS 400 (Rifaximin) is a non-systemic antibiotic primarily used to treat bacterial infections of the gastrointestinal tract. Unlike most antibiotics, Rifaximin has very poor systemic absorption, meaning it stays largely within the gut lumen where it exerts its antibacterial effects. This localized action makes it highly effective against gut bacteria without significantly affecting the beneficial bacteria elsewhere in the body or causing widespread systemic side effects. It works by inhibiting bacterial RNA synthesis, thereby preventing bacterial growth and replication.

It is commonly prescribed for conditions such as traveler's diarrhea caused by non-invasive strains of E. coli, irritable bowel syndrome with diarrhea (IBS-D), and hepatic encephalopathy. In hepatic encephalopathy, Rifaximin reduces the production and absorption of ammonia and other toxins by gut bacteria, which can improve neurological function in patients with liver disease. Its targeted action and minimal systemic exposure make it a unique and valuable option for managing specific gastrointestinal bacterial overgrowth and related conditions, offering relief from symptoms like diarrhea, bloating, and abdominal pain.

Uses

• Treatment of traveler's diarrhea
• Management of irritable bowel syndrome with diarrhea (IBS-D)
• Reduction of hepatic encephalopathy recurrence
• Treatment of small intestinal bacterial overgrowth (SIBO)

Directions For Use

Take one tablet orally, with or without food, as directed by your physician. Complete the full course of treatment even if symptoms improve.

Benefits

• Targeted action within the gut
• Minimal systemic absorption
• Effective against specific gut bacteria
• Reduces diarrhea and bloating
• Improves symptoms of IBS-D
• Lowers ammonia levels in hepatic encephalopathy

Side Effects

• Abdominal pain
• Nausea
• Diarrhea
• Constipation
• Headache
• Dizziness
• Fatigue
• Peripheral edema
• Flatulence
• Fever
• Rash
• Muscle spasms

Safety Measures

• Alcohol - Moderate alcohol consumption is generally acceptable, but it may exacerbate underlying gastrointestinal conditions being treated.
• Pregnancy - Consult your doctor before use. Limited data available; use only if potential benefit justifies potential risk to the fetus.
• Breastfeeding - Consult your doctor before use. It is unknown if Rifaximin is excreted in human milk; caution is advised.
• Liver - Use with caution in patients with severe liver impairment, especially in hepatic encephalopathy, as systemic exposure may increase.
• Kidney - No specific dose adjustment is typically required for kidney impairment due to minimal systemic absorption.
• Lung - No specific contraindications or precautions related to lung conditions are generally noted for Rifaximin.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.